FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...
The von Meissner Foundation was created in 1988 thanks to the legacy of Mrs Gertrude von Meissner, in memory of her daughter ...
Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") today announced that it has reached an agreement with the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback